oral tirzepatide efficacy Safety and of as an add-on to single antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial Oral Tirzepatide: What the Research

Nausea and vomiting As mentioned above, Wegovy slows down how fast the stomach empties after eating, which can lead to nausea and potentially cause vomiting

Drawing medicine out of a vial

Which has been amazing

What we know Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form

US Holds Largest Share in North America Driven by High Healthcare Spending The US GLP-1 receptor agonist market held the largest share in North America in 2025 due to its patient population, favorable regulatory environment, and high healthcare spending per capita

A 2023 paper found that people who added a small amount of allulose to their meals saw a reduction of between 10 to 15 percent in how much their glucose rose after eating